<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Thu, 05 Mar 2026 21:49:06 -0500--><rss version="2.0">
    <channel>
        <title>DiaMedica Therapeutics, Inc. (DMAC) Media</title>
        <link>https://www.diamedica.com/media/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/diamedica/files/theme/images/logo-sm.png</url>
                <title>DiaMedica Therapeutics, Inc. Logo</title>
                <link>https://www.diamedica.com</link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[It's a dangerous complication of pregnancy — but a new drug holds promise]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.npr.org/2026/02/14/nx-s1-5708744/preeclampsia-pregnancy-complication-treatment</link>
                <pubDate>Sat, 14 Feb 26 00:00:00 -0500</pubDate>
                <guid isPermalink="true">https://www.npr.org/2026/02/14/nx-s1-5708744/preeclampsia-pregnancy-complication-treatment</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Overcoming Drug Development Obstacles for Some of the Most Challenging Ischemic Conditions]]></title>
                <description><![CDATA[]]></description>
                <link>https://clinicaledge.xtalks.com/magazine/issue7/stroke-research</link>
                <pubDate>Thu, 12 Feb 26 00:00:00 -0500</pubDate>
                <guid isPermalink="true">https://clinicaledge.xtalks.com/magazine/issue7/stroke-research</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[DDW Winter 2025/2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://d1io3yog0oux5.cloudfront.net/_81508af6e9e4bcbfa7bfa36cad78826b/diamedica/files/DDW_-_2025-2026_Winter_Edition.pdf		</link>
                <pubDate>Thu, 22 Jan 26 00:00:00 -0500</pubDate>
                <guid isPermalink="true">https://d1io3yog0oux5.cloudfront.net/_81508af6e9e4bcbfa7bfa36cad78826b/diamedica/files/DDW_-_2025-2026_Winter_Edition.pdf		</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[More Patient Insight — And Funding— Needed To Advance Preeclampsia Research]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.clinicalleader.com/doc/more-patient-insight-and-funding-needed-to-advance-preeclampsia-research-0001</link>
                <pubDate>Thu, 18 Dec 25 00:00:00 -0500</pubDate>
                <guid isPermalink="true">https://www.clinicalleader.com/doc/more-patient-insight-and-funding-needed-to-advance-preeclampsia-research-0001</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Recombinant KLK1: the next step in stroke and preeclampsia treatment]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.drugtargetreview.com/article/190279/recombinant-klk1-the-next-step-in-stroke-and-preeclampsia-treatment/</link>
                <pubDate>Wed, 05 Nov 25 00:00:00 -0500</pubDate>
                <guid isPermalink="true">https://www.drugtargetreview.com/article/190279/recombinant-klk1-the-next-step-in-stroke-and-preeclampsia-treatment/</guid>
                                                                            </item>
            </channel>
</rss>